Serena Bhela, MD
Internal Medicine · Antioch
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 15
- 2 carriers
- Offices
- 3
- Since medical school
- 13 years
- Graduated 2013
Offices
3 locations · West Coast Kidney · 56 clinicians in this group
Hospitals listed: 052758 · 052759 · Contra Costa Regional Medical Center · John Muir Medical Center - Concord Campus · John Muir Medical Center - Walnut Creek Campus · Sutter Delta Medical Center. That is not proof they admit you there this week.
Plans that list them
15 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bhela’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
15 of 15 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A150813 · Current
Licensed to practise in California · since 2017 · expires 2028-09-30 · St. George'S University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
- American Board of Internal Medicine - Nephrology
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Contra Costa Regional Medical CenterMartinez, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Contra Costa Health ServicesPatients rate it 3 of 5 · 73% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.167, Oct 2024 – Sep 2025
- John Muir Medical Center - Concord CampusConcord, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of John Muir Health, which runs 3 hospitalsPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.235, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.675, Oct 2024 – Sep 2025
- John Muir Medical Center - Walnut Creek CampusWalnut Creek, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of John Muir Health, which runs 3 hospitalsPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Abdominopelvic accidental puncture or laceration rate: 2.01 (1.17 to 2.85) · 2,206 cases, Jul 2022 – Jun 2024Worse than the national rate — Death rate among surgical inpatients with serious treatable complications: 222.42 (177.82 to 267.02) · 120 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.4 (0.91 to 1.9) · 9,764 cases, Jul 2022 – Jun 2024Worse than the national rate — SSI - Colon Surgery: 2.734, Oct 2024 – Sep 2025Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.536, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.341, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.455, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.245, Oct 2024 – Sep 2025
- Sutter Delta Medical CenterAntioch, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.173, Oct 2024 – Sep 2025
See every measure and the patient survey for Contra Costa Regional Medical Center
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 1 better, 4 the same, 1 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.167 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.99 (0 to 2.04) · 188 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.08 (0.63 to 1.53) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.8 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.4 · 114 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.3 · 27 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 321 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.44) · 1,181 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.47) · 1,198 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.2 (0.67 to 5.72) · 216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 71 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.5 (0.82 to 4.18) · 195 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.36 (1.01 to 19.71) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.88 (0.69 to 9.08) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.07 (0.55 to 3.58) · 67 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.93 (0 to 2.03) · 981 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.948 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 2.027 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.3 · 101 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 52.2 · 126 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -53.6 · 112 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 87 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.7 to 8.6) · 95 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (8.8 to 17.8) · 95 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 35 cases | None | Jul 2023 – Jun 2025 |
What patients said (521 patients answered, 10% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 79% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 73% |
| Staff "always" explained possible side effects | 54% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for John Muir Medical Center - Concord Campus
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.235 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.675 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.11 (0.21 to 2) · 1,612 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.77 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 184.13 (136.65 to 231.6) · 86 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.2 · 175 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.6 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.4 · 172 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8 · 537 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.5 · 434 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13 · 215 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 3,208 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.32 (0.13 to 0.51) · 7,626 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 8,660 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.1 (1.29 to 4.91) · 2,723 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.21 (0 to 2.51) · 1,208 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3 (1.7 to 4.3) · 2,355 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.77 (3.24 to 12.3) · 1,216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.43 (0.43 to 6.43) · 1,253 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.93 (0.47 to 3.4) · 388 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.14 (0.58 to 1.69) · 6,288 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 263 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.636 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.254 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.904 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.5 · 312 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.1 · 768 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -6.8 · 295 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.1 · 648 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 31.1 · 433 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 504 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.7 (5.1 to 8.8) · 476 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.9 (10.5 to 15.7) · 476 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 8.8 · 154 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.7 · 186 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (9.9 to 17.9) · 192 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.2) · 546 cases | No different | Jan 2024 – Dec 2024 |
What patients said (521 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
See every measure and the patient survey for John Muir Medical Center - Walnut Creek Campus
Behind the star rating — Deaths: 3 better, 2 the same, 2 worse of 7 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 3 better, 5 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 2.01 (1.17 to 2.85) · 2,206 cases | Worse | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 222.42 (177.82 to 267.02) · 120 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.4 (0.91 to 1.9) · 9,764 cases | Worse | Jul 2022 – Jun 2024 |
| SSI - Colon SurgeryInfections | 2.734 | Worse | Oct 2024 – Sep 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.536 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.341 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.455 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.245 | Better | Oct 2024 – Sep 2025 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.14 (0.87 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 131 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 148 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 695 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.5 · 827 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.1 · 509 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 4,483 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.35 (0.18 to 0.53) · 11,630 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.05 to 0.39) · 11,793 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.69 to 4.96) · 3,268 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.37 (0 to 2.94) · 1,631 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.76 (1.43 to 4.09) · 3,066 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.12 (0.22 to 12.02) · 1,580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.43 (1.21 to 7.64) · 1,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.82 (0.4 to 3.24) · 685 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 615 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 1.88 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 93 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 729 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.1 · 91 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13 · 736 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 34.8 · 842 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.7 · 818 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.3 to 8.4) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.2 to 15.5) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 584 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 139 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.9) · 222 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 321 cases | No different | Jan 2024 – Dec 2024 |
What patients said (758 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Sutter Delta Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.173 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.98 (0 to 2.03) · 561 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.47 to 1.29) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 176.46 (114.75 to 238.17) · 31 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 113 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.3 · 260 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.2 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.5 · 56 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 1,274 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.02 to 0.46) · 3,285 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 3,374 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.47 (1.02 to 5.93) · 364 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.16 (0.49 to 3.83) · 323 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.63 (0 to 18.4) · 26 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.71 (0.2 to 3.22) · 81 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.24 (0 to 1.07) · 2,713 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.962 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 116 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 316 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 20 · 83 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 7.1 · 298 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 27.3 · 269 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 283 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.7 to 17.1) · 529 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 45 cases | No different | Jan 2024 – Dec 2024 |
What patients said (610 patients answered, 13% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 70% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 70% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 60% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 64% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$278,096
Medicare paid this office $278,096 for 619 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 4 or more physician visits per month (20 years or older) | 37 | $78,129 | $313 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 307 | $68,363 | $69 |
| Return visit (30+ min) | 218 | $55,779 | $111 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 90 | $13,783 | $150 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 45 | $11,958 | $59 |
See all 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 37 | $78,129 | $313 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 307 | $68,363 | $69 |
| Return visit (30+ min) | 218 | $55,779 | $111 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 90 | $13,783 | $150 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 45 | $11,958 | $59 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 67 | $8,739 | $115 |
| New patient visit (45+ min) | 55 | $8,510 | $155 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 236 | $6,866 | $14 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 44 | $5,750 | $46 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 15 | $5,664 | $257 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $3,040 | $105 |
Who their Medicare patients are
619 Original Medicare patients in 2024. Average age 75 · Under 65 13% · 85 and older 19% · Women 46% · Also on Medicaid 43% · Health risk score 4.63. Sicker patients than 9 in 10 peers; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 61% · Heart failure 54% · Coronary heart disease 52% · Atrial fibrillation 40% · Depression 31% · COPD 29% · Cancer 22% · Stroke 22% · Dementia 17%.
The office billed $729,188, Medicare allowed $359,568 and paid $278,096; for 2,901 services of 25 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 619 | 2,901 | 75 | 4.63 | $729,188 | $278,096 |
| 2023 | 516 | 1,736 | 74 | 4.63 | $495,013 | $185,700 |
| 2022 | 551 | 1,914 | 73 | 4.64 | $564,224 | $205,443 |
| 2021 | 624 | 2,358 | 73 | 4.91 | $646,473 | $256,745 |
| 2020 | 640 | 2,068 | 71 | 5.20 | $457,409 | $179,251 |
| 2019 | 487 | 1,857 | 74 | 3.60 | $417,715 | $206,805 |
| 2018 | 234 | 854 | 72 | 3.77 | $181,060 | $93,715 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 243 | $53,030 | $70 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 21 | $45,262 | $319 |
| Return visit (30+ min) | 178 | $44,205 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 80 | $12,215 | $153 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 52 | $11,118 | $108 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 69 | $7,885 | $111 |
| New patient visit (45+ min) | 33 | $4,668 | $141 |
2022: 10 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 24 | $49,674 | $309 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 249 | $38,483 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 150 | $35,180 | $92 |
| Return visit (30+ min) | 145 | $33,352 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 122 | $21,790 | $169 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 13 | $7,599 | $271 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 58 | $7,461 | $120 |
| New patient visit (45+ min) | 44 | $6,328 | $144 |
| Telephone medical discussion with physician, 5-10 minutes | 12 | $445 | $37 |
| Manual urinalysis test with examination using microscope, non-automated | 18 | $71 | $4 |
2021: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 328 | $69,981 | $64 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 41 | $69,546 | $320 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 127 | $24,746 | $92 |
| Return visit (30+ min) | 97 | $20,882 | $122 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 152 | $19,539 | $118 |
| Short return visit (20+ min) | 96 | $14,302 | $74 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 74 | $13,351 | $178 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 18 | $7,621 | $272 |
| New patient visit (45+ min) | 39 | $5,958 | $153 |
| New patient visit (30+ min) | 23 | $2,048 | $89 |
| Telephone medical discussion with physician, 11-20 minutes | 16 | $1,239 | $65 |
2020: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 385 | $77,699 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 199 | $27,097 | $124 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 41 | $22,903 | $260 |
| Short return visit (20+ min) | 104 | $10,927 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 65 | $10,286 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 56 | $9,653 | $172 |
| Return visit (30+ min) | 47 | $4,411 | $80 |
| New patient visit (30+ min) | 40 | $3,988 | $100 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 12 | $3,316 | $221 |
| New patient visit (45+ min) | 14 | $1,964 | $140 |
| Dialysis services, 1 physician visit per month (20 years or older) | 15 | $1,681 | $112 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $1,076 | $72 |
| Manual urinalysis test with examination using microscope, non-automated | 18 | $72 | $4 |
2019: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 170 | $50,135 | $89 |
| Return visit (30+ min) | 201 | $40,927 | $88 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 44 | $30,660 | $247 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 130 | $28,099 | $169 |
| Dialysis services, 1 physician visit per month (20 years or older) | 23 | $17,178 | $146 |
| New patient visit (45+ min) | 110 | $12,982 | $118 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 29 | $8,638 | $201 |
| Short return visit (20+ min) | 93 | $6,735 | $61 |
| New patient visit (30+ min) | 30 | $2,881 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $2,754 | $63 |
| Hemodialysis procedure with physician evaluation | 17 | $1,576 | $63 |
2018: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 94 | $41,199 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 76 | $16,105 | $175 |
| New patient visit (45+ min) | 87 | $12,027 | $138 |
| Return visit (30+ min) | 53 | $7,603 | $95 |
| Critical care, first 30-74 minutes | 16 | $4,542 | $189 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 12 | $3,510 | $206 |
| Dialysis services, 1 physician visit per month (20 years or older) | 13 | $3,392 | $147 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,006 | $63 |
| Short return visit (20+ min) | 12 | $791 | $66 |
Medicaid work
$58,255 in 2024
Medicaid paid $58,255 for 693 billed services this clinician did in 2024, up to 59 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 508 | $29,635 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 55 | $18,944 |
| Return visit (30+ min) | 66 | $7,181 |
| 1ST HOSP IP/OBS HIGH 75 | 12 | $2,038 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 52 | $457 |
| 2024 | 693 | 5 | 59 | $58,255 |
| 2023 | 630 | 4 | 37 | $21,065 |
| 2022 | 814 | 5 | 33 | $23,388 |
| 2021 | 1,323 | 7 | 66 | $34,518 |
| 2020 | 1,103 | 5 | 46 | $22,440 |
| 2019 | 145 | 2 | 17 | $5,423 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 477 | $15,095 |
| Return visit (30+ min) | 124 | $3,872 |
| Service | 13 | $1,067 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 16 | $1,032 |
2022
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 433 | $9,547 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 189 | $6,352 |
| Return visit (30+ min) | 153 | $4,062 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 13 | $2,081 |
| 1ST HOSP IP/OBS HIGH 75 | 26 | $1,346 |
2021
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 764 | $13,574 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 230 | $7,273 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 56 | $4,080 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 105 | $3,870 |
| 1ST HOSP IP/OBS HIGH 75 | 52 | $3,448 |
| Return visit (30+ min) | 39 | $1,367 |
| Short return visit (20+ min) | 77 | $906 |
2020
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 970 | $18,169 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 92 | $2,635 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 13 | $936 |
| Return visit (30+ min) | 16 | $592 |
| Short return visit (20+ min) | 12 | $108 |
2019
| Return visit (30+ min) | 116 | $4,877 |
| Short return visit (20+ min) | 29 | $546 |
Drugs they prescribed that Part D paid
$218,646
Pharmacies billed $218,646 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 928) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
691 generic and 237 brand-name prescriptions · $218,646 in drug cost · 19 antibiotic prescriptions to 18 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Farxiga | 69 | $70,810 | $1,026 |
| Jardiance | 48 | $57,730 | $1,203 |
| Lokelma | 65 | $28,283 | $435 |
| Veltassa | 19 | $16,081 | $846 |
| Sevelamer Carbonate | 17 | $9,041 | $532 |
See all 16 drugs
| Farxiga | 69 | $70,810 | $1,026 |
| Jardiance | 48 | $57,730 | $1,203 |
| Lokelma | 65 | $28,283 | $435 |
| Veltassa | 19 | $16,081 | $846 |
| Sevelamer Carbonate | 17 | $9,041 | $532 |
| Bumetanide | 27 | $1,205 | $45 |
| Nifedipine Er | 16 | $987 | $62 |
| Lisinopril | 104 | $630 | $6 |
| Furosemide | 103 | $471 | $5 |
| Losartan | 67 | $425 | $6 |
| Hydralazine | 37 | $424 | $11 |
| Amlodipine Besylate | 80 | $266 | $3 |
| Carvedilol | 34 | $242 | $7 |
| Calcitriol | 32 | $179 | $6 |
| Famotidine | 18 | $173 | $10 |
| Hydrochlorothiazide | 24 | $126 | $5 |
Year by year
| 2024 | 928 | 208 | 0% (0) | 26% | $218,646 |
| 2023 | 727 | 161 | 0% (0) | 23% | $151,607 |
| 2022 | 736 | 160 | 0% (0) | 23% | $101,047 |
| 2021 | 634 | 139 | 0% (0) | 12% | $35,909 |
| 2020 | 547 | 143 | 0% (0) | 20% | $49,535 |
| 2019 | 612 | 120 | None | 20% | $59,881 |
| 2018 | 60 | 32 | 0% (0) | None | $1,457 |
| 2017 | 41 | 11 | 0% (0) | 54% | $26,706 |
| 2016 | 228 | 31 | 0% (0) | None | $20,311 |
| 2015 | 226 | 33 | None | None | $7,732 |
| 2014 | 223 | 38 | 0% (0) | None | $19,352 |
| 2013 | 150 | 24 | None | None | $26,021 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Lokelma | 69 | $45,995 | $667 |
| Farxiga | 50 | $45,923 | $918 |
| Jardiance | 17 | $18,941 | $1,114 |
| Nifedipine Er | 20 | $1,850 | $93 |
| Bumetanide | 18 | $1,272 | $71 |
| Hydralazine | 42 | $1,195 | $28 |
| Losartan | 67 | $1,124 | $17 |
| Amlodipine Besylate | 76 | $932 | $12 |
| Lisinopril | 77 | $714 | $9 |
| Carvedilol | 48 | $681 | $14 |
| Furosemide | 68 | $670 | $10 |
| Calcitriol | 31 | $392 | $13 |
| Hydrochlorothiazide | 26 | $196 | $8 |
| Cephalexin | 13 | $70 | $5 |
2022: 15 drugs
| Lokelma | 69 | $35,516 | $515 |
| Farxiga | 41 | $27,884 | $680 |
| Jardiance | 14 | $12,228 | $873 |
| Calcitriol | 49 | $913 | $19 |
| Calcium Acetate | 17 | $876 | $52 |
| Bumetanide | 16 | $853 | $53 |
| Hydralazine | 33 | $645 | $20 |
| Nifedipine Er | 15 | $490 | $33 |
| Amlodipine Besylate | 77 | $443 | $6 |
| Losartan | 68 | $436 | $6 |
| Lisinopril | 107 | $399 | $4 |
| Metolazone | 13 | $288 | $22 |
| Furosemide | 69 | $286 | $4 |
| Carvedilol | 27 | $205 | $8 |
| Hydrochlorothiazide | 17 | $116 | $7 |
2021: 12 drugs
| Lokelma | 26 | $15,536 | $598 |
| Nifedipine Er | 50 | $1,530 | $31 |
| Calcitriol | 39 | $1,060 | $27 |
| Hydralazine | 59 | $958 | $16 |
| Amlodipine Besylate | 89 | $529 | $6 |
| Losartan | 53 | $528 | $10 |
| Metolazone | 18 | $454 | $25 |
| Furosemide | 70 | $349 | $5 |
| Lisinopril | 52 | $224 | $4 |
| Potassium Chloride | 11 | $122 | $11 |
| Hydrochlorothiazide | 22 | $91 | $4 |
| Allopurinol | 14 | $87 | $6 |
2020: 14 drugs
| Veltassa | 29 | $25,744 | $888 |
| Nifedipine Er | 49 | $1,787 | $36 |
| Calcium Acetate | 14 | $1,497 | $107 |
| Metoprolol | 18 | $590 | $33 |
| Potassium Chloride | 35 | $524 | $15 |
| Hydralazine | 37 | $448 | $12 |
| Allopurinol | 29 | $439 | $15 |
| Calcitriol | 25 | $369 | $15 |
| Furosemide | 56 | $303 | $5 |
| Amlodipine Besylate | 65 | $281 | $4 |
| Losartan | 25 | $252 | $10 |
| Hydrochlorothiazide | 16 | $150 | $9 |
| Lisinopril | 29 | $150 | $5 |
| Metoprolol | 12 | $80 | $7 |
2019: 14 drugs
| Veltassa | 26 | $23,711 | $912 |
| Sevelamer Carbonate | 13 | $7,521 | $579 |
| Nifedipine Er | 61 | $1,918 | $31 |
| Calcium Acetate | 17 | $1,099 | $65 |
| Allopurinol | 47 | $482 | $10 |
| Calcitriol | 26 | $405 | $16 |
| Metoprolol | 29 | $334 | $12 |
| Hydralazine | 22 | $302 | $14 |
| Potassium Chloride | 28 | $283 | $10 |
| Amlodipine Besylate | 66 | $282 | $4 |
| Lisinopril | 52 | $263 | $5 |
| Hydrochlorothiazide | 35 | $232 | $7 |
| Losartan | 23 | $196 | $9 |
| Furosemide | 45 | $167 | $4 |
2018: 1 drug
| Amlodipine Besylate | 11 | $99 | $9 |
2016: 4 drugs
| Alendronate | 13 | $63 | $5 |
| Amlodipine Besylate | 23 | $55 | $2 |
| Omeprazole | 12 | $48 | $4 |
| Hydrochlorothiazide | 19 | $34 | $2 |
2015: 6 drugs
| Simvastatin | 13 | $101 | $8 |
| Alendronate | 16 | $62 | $4 |
| Omeprazole | 13 | $55 | $4 |
| Hydrochlorothiazide | 11 | $29 | $3 |
| Amlodipine Besylate | 16 | $29 | $2 |
| Metoprolol | 13 | $22 | $2 |
2014: 2 drugs
| Amlodipine Besylate | 16 | $84 | $5 |
| Hydrochlorothiazide | 13 | $56 | $4 |
2013: 1 drug
| Amlodipine Besylate | 13 | $82 | $6 |
Money from drug and device companies
$708 in 2025
| 2025 | 7 | 26 | None | $708 |
| 2024 | 9 | 24 | None | $419 |
| 2023 | 10 | 25 | None | $474 |
| 2022 | 5 | 7 | None | $239 |
| 2021 | 7 | 9 | None | $184 |
| 2020 | 2 | 3 | None | $69 |
| 2019 | 9 | 22 | None | $469 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Tavneos | $246 | 6 payments
|
| Fresenius USA Marketing | Velphoro | $156 | 7 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $111 | 6 payments
|
| Novartis Pharmaceuticals | Fabhalta | $83 | 3 payments
|
| Mallinckrodt Hospital Products | Acthar | $45 | 2 payments
|
| Travere Therapeutics | None | $33 | 1 payment
|
See all 26 published payments
| Fresenius USA Marketing | Meals · 2025-12-17 | Velphoro | $14 |
| Fresenius USA Marketing | Meals · 2025-11-13 | Velphoro | $22 |
| Amgen | Meals · 2025-11-05 | Krystexxa | $12 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-21 | Farxiga | $14 |
| Fresenius USA Marketing | Meals · 2025-10-21 | Velphoro | $25 |
| Amgen | Meals · 2025-10-01 | Tavneos | $133 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-20 | Farxiga | $21 |
| Novartis Pharmaceuticals | Meals · 2025-09-19 | Fabhalta | $29 |
| Mallinckrodt Hospital Products | Meals · 2025-09-17 | Acthar | $14 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-13 | Farxiga | $16 |
| Amgen | Meals · 2025-09-11 | Krystexxa | $10 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-21 | Farxiga | $21 |
| Amgen | Meals · 2025-08-21 | Krystexxa | $31 |
| Fresenius USA Marketing | Meals · 2025-08-21 | Velphoro | $23 |
| Fresenius USA Marketing | Meals · 2025-07-30 | Velphoro | $24 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-11 | Farxiga | $15 |
| Amgen | Meals · 2025-07-10 | Krystexxa | $34 |
| Novartis Pharmaceuticals | Meals · 2025-06-19 | Fabhalta | $18 |
| Fresenius USA Marketing | Meals · 2025-06-05 | Velphoro | $25 |
| Fresenius USA Marketing | Meals · 2025-04-24 | Velphoro | $24 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-04 | Farxiga | $23 |
| Amgen | Meals · 2025-03-25 | Tavneos | $26 |
| Travere Therapeutics | Meals · 2025-03-14 | None | $33 |
| Novartis Pharmaceuticals | Meals · 2025-02-21 | Fabhalta | $36 |
| Mallinckrodt Hospital Products | Meals · 2025-02-21 | Acthar | $31 |
| Ardelyx | Meals · 2025-01-30 | Ibsrela | $33 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $419
| Fresenius USA Marketing | Velphoro | $155 | 10 payments
|
| Amgen | Krystexxa | $65 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $40 | 2 payments
|
| Ardelyx | Ibsrela | $39 | 2 payments
|
| Travere Therapeutics | None | $33 | 3 payments
|
| Aurinia Pharma U.S. | Lupkynis | $32 | 1 payment
|
| Mallinckrodt Hospital Products | Acthar | $24 | 1 payment
|
| Otsuka America Pharmaceutical | Jynarque | $19 | 1 payment
|
| Vifor Pharma | Veltassa | $13 | 1 payment
|
2023: $474
| AstraZeneca Pharmaceuticals LP | Lokelma | $248 | 11 payments
|
| Otsuka America Pharmaceutical | Jynarque | $50 | 2 payments
|
| Fresenius USA Marketing | Velphoro | $42 | 2 payments
|
| Novo Nordisk | Rybelsus | $21 | 1 payment
|
| Ardelyx | Ibsrela | $21 | 1 payment
|
| Calliditas Therapeutics US | Tarpeyo | $20 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $20 | 1 payment
|
| Novartis Pharmaceuticals | None | $19 | 1 payment
|
| Mallinckrodt Hospital Products | Acthar | $18 | 1 payment
|
| GlaxoSmithKline | Jesduvroq | $15 | 1 payment
|
2022: $239
| Bayer HealthCare Pharmaceuticals | Kerendia | $146 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $38 | 2 payments
|
| Vifor Pharma | Veltassa | $22 | 1 payment
|
| GlaxoSmithKline | Benlysta | $18 | 1 payment
|
| Horizon Therapeutics plc | Krystexxa | $15 | 1 payment
|
2021: $184
| AstraZeneca Pharmaceuticals LP | Lokelma | $48 | 3 payments
|
| GlaxoSmithKline | Benlysta | $34 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $24 | 1 payment
|
| Otsuka America Pharmaceutical | Jynarque | $22 | 1 payment
|
| Daiichi Sankyo | Injectafer | $21 | 1 payment
|
| Aurinia Pharma U.S. | Lupkynis | $18 | 1 payment
|
| Ultragenyx Pharmaceutical | Crysvita | $16 | 1 payment
|
2020: $69
| Amgen | Parsabiv | $42 | 2 payments
|
| Otsuka America Pharmaceutical | Jynarque | $27 | 1 payment
|
2019: $469
| Relypsa | Veltassa | $156 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $88 | 5 payments
|
| OPKO Pharmaceuticals | Rayaldee | $58 | 4 payments
|
| Akebia Therapeutics | Auryxia | $52 | 3 payments
|
| Amgen | Parsabiv | $34 | 2 payments
|
| Otsuka America Pharmaceutical | Jynarque | $30 | 2 payments
|
| Alexion Pharmaceuticals | Soliris | $19 | 1 payment
|
| Horizon Therapeutics plc | Krystexxa | $18 | 1 payment
|
| Fresenius USA Marketing | None | $15 | 1 payment
|
Professional record
- NPI
- 1275873812
- Licence
- CA A150813California A150813: Current · expires 2028-09-30
- Group
- West Coast Kidney
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 3230 Beard Rd Ste 1, Napa, CA, 94558
- NPI first listed
- 2013-02-19
- NPI last updated
- 2018-06-13
This is when the NPI record was last certified, not a medical board exam.